AI assistant
AstraZeneca PLC — Director's Dealing 2013
Nov 1, 2013
5229_dirs_2013-11-01_43093a2c-4868-4e45-a538-453935e8e3ea.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 0143S
AstraZeneca PLC
01 November 2013
Transaction by Person Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
On 31 October 2013, the interest of Mr Pascal Soriot, a person discharging managerial responsibilities, in the ordinary shares of AstraZeneca PLC changed as detailed below.
The change in interest relates to the previously announced award of restricted shares made in October 2012 in connection with Mr Soriot's appointment as Chief Executive Officer. The award vests in three tranches over three years.
After sufficient shares were withheld to satisfy certain tax obligations arising on the vesting, Mr Soriot has become beneficially entitled to and has received 23,981 shares into a personal brokerage account in respect of the first tranche of the award.
For tax purposes, the fair market value of the shares at vest was 3330 pence per share being the closing price of AstraZeneca ordinary shares on the last trading day preceding the vesting day.
Following the vesting, Mr Soriot has a total interest in 411,917 AstraZeneca shares.
A C N Kemp
Company Secretary
1 November 2013
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSUAOOROOAARAA